Scalable Automation That Advances Biotech Production
The biotechnology industry is experiencing unprecedented growth as cell and gene therapies move from clinical trials to commercial production. This rapid expansion creates unique manufacturing challenges that traditional pharmaceutical infrastructure wasn't designed to address.
Biotechnology manufacturing differs fundamentally from conventional drug production. Cell and gene therapies often require personalized approaches, small batch sizes and high-value processes where a single batch can be worth tens of thousands of dollars. Manual documentation and legacy systems struggle to support the level of precision, traceability and speed that biotechnology demands.
Purpose-built automation helps biotechnology companies modernize manufacturing with systems designed to meet these unique requirements. Integrate process control, batch execution and quality management to support everything from clinical manufacturing to commercial-scale biologics production. Reduce manual documentation burden while providing the visibility and audit trails that regulatory frameworks require, including 21 CFR Part 11/EU Annex 11 and current Good Manufacturing Practices (cGMPs).
